Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect.

Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy.

Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort.